UK researchers are launching a Phase 2 trial looking at a cannabis-based therapy for Alzheimer’s
February 15, 2019 at 14:35 PM EST
A research team at King’s College London is launching a Phase 2 trial of a cannabis-based therapy for the treatment of certain dementia symptoms, according to a Friday announcement by Alzheimer’s Research UK, which will be funding the study.